Action/Kinetics:
Onset is more rapid but effect is less consistent than that of propylthiouracil. Bioavailability may be affected by food.
t
1/2: 4-14 hr.
Onset: 10-20 days.
Time to peak effect: 2-10 weeks.
t
1/2: 6-13 hr. Crosses the placenta; high levels appear in breast milk. Metabolized in the liver and excreted through the kidneys (7% unchanged).
Special Concerns:
Incidence of hepatic toxicity may be greater than for propylthiouracil.
How Supplied:Tablet: 5 mg, 10 mg
Dosage ?TabletsMild hyperthyroidism. Adults, initial: 15 mg/day.
Moderately severe hyperthyroidism. Adults, initial: 30-40 mg/day.
Severe hyperthyroidism. Adults, initial: 60 mg/day. For hyperthyroidism, the daily dose is usually given in three equal doses 8 hr apart.
Maintenance: 5-15 mg/day as a single dose or divided into two doses.
Pediatric: 0.4 mg/kg given once daily or divided into two doses;
maintenance: 0.2 mg/kg. Alternatively,
initial: 0.5-0.7 mg/kg/day (15-20 mg/m
2/day in three divided doses);
maintenance:
1/3-
2/3 initial dose when client is euthyroid up to a maximum of 30 mg/day.
Thyrotoxic crisis. Adults, 15-20 mg/4 hr during the first day as an adjunct to other treatments.